Adaptive Biotechnologies Quote - ADPT

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

7.86

Bid

7.80

Offer

8.20

Volume

0.00 Day's Range 0.00

2.28 52 Week Range 8.33

Market Cap

1.16B

Previous Close

7.86

Open

Last Trade

7.7

Last Trade Time

20:31:46

Financial Volume

VWAP

Average Volume (3m)

1,356,332

Shares Outstanding

147,579,486

Dividend Yield

PE Ratio

-5.15

Earnings Per Share (EPS)

-1.53

Revenue

170.28M

Net Profit

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.adaptivebiotech.com

Headquarters

Olympia, Washington, USA

Founded

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was US$7.86. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of US$ 2.28 to US$ 8.33.

Adaptive Biotechnologies currently has 147,579,486 shares in issue. The market capitalisation of Adaptive Biotechnologies is US$1.16 billion. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -5.15.

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

SEATTLE and FORT MYERS, Fla., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics...

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

SEATTLE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies show depth of response at 10-6 provides more accurate assessment...

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.22	-2.72277227723	8.08	8.26	7.45	836828	7.81874156	CS
4	1.48	23.197492163	6.38	8.33	5.975	1553922	7.2078741	CS
12	1.86	31	6	8.33	4.27	1356332	6.31296697	CS
26	3.2	68.669527897	4.66	8.33	3.91	1217556	5.49571169	CS
52	3.91	98.9873417722	3.95	8.33	2.28	1394512	4.32159326	CS
156	-7.26	-48.0158730159	15.12	18.02	2.28	1303299	6.64266154	CS
260	-22.5	-74.1106719368	30.36	71.25	2.28	1137807	16.9011879	CS

ADPT - Frequently Asked Questions (FAQ)

What is the current Adaptive Biotechnologies share price?

The current share price of Adaptive Biotechnologies is US$ 7.86

How many Adaptive Biotechnologies shares are in issue?

Adaptive Biotechnologies has 147,579,486 shares in issue

What is the market cap of Adaptive Biotechnologies?

The market capitalisation of Adaptive Biotechnologies is USD 1.16B

What is the 1 year trading range for Adaptive Biotechnologies share price?

Adaptive Biotechnologies has traded in the range of US$ 2.28 to US$ 8.33 during the past year

What is the PE ratio of Adaptive Biotechnologies?

The price to earnings ratio of Adaptive Biotechnologies is -5.15

What is the cash to sales ratio of Adaptive Biotechnologies?

The cash to sales ratio of Adaptive Biotechnologies is 6.81

What is the reporting currency for Adaptive Biotechnologies?

Adaptive Biotechnologies reports financial results in USD

What is the latest annual turnover for Adaptive Biotechnologies?

The latest annual turnover of Adaptive Biotechnologies is USD 170.28M

What is the latest annual profit for Adaptive Biotechnologies?

The latest annual profit of Adaptive Biotechnologies is USD -225.25M

What is the registered address of Adaptive Biotechnologies?

The registered address for Adaptive Biotechnologies is 711 CAPITOL WAY S STE 204, UNITED STATES, OLYMPIA, WASHINGTON, 98501 1267

What is the Adaptive Biotechnologies website address?

The website address for Adaptive Biotechnologies is www.adaptivebiotech.com

Which industry sector does Adaptive Biotechnologies operate in?

Adaptive Biotechnologies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TDTHTrident Digital Tech Holdings Ltd	US$ 2.045 (115.26%)	6.49M
TCTMTCTM Kids IT Education Inc	US$ 0.3108 (71.62%)	6.74M
EDRYEuroDry Ltd	US$ 18.34 (63.75%)	8
OPOFOld Point Financial Corporation	US$ 39.05 (59.98%)	4
CCECCapital Clean Energy Carriers Corporation	US$ 30.40 (59.00%)	12
NYAXNAYAX Ltd	US$ 17.01 (-56.16%)	6
CLRCClimateRock	US$ 6.00 (-49.46%)	277
CEPOCantor Equity Partners I Inc	US$ 6.01 (-40.20%)	1
ENVBEnveric Biosciences Inc	US$ 2.41 (-38.21%)	124.59k
FSFGFirst Savings Financial Group Inc	US$ 15.01 (-37.98%)	2
CLEUChina Liberal Education Holdings Ltd	US$ 0.1385 (-6.55%)	17.72M
KITTNauticus Robotics Inc	US$ 2.33 (49.36%)	10.83M
TCTMTCTM Kids IT Education Inc	US$ 0.3108 (71.62%)	6.74M
TDTHTrident Digital Tech Holdings Ltd	US$ 2.045 (115.26%)	6.49M
EVTVEnvirotech Vehicles Inc	US$ 0.3238 (-6.55%)	4.01M